Journal vs. docs: malnutrition spat

The editor of __The Lancet__ has banned members of international aid group Doctors Without Borders (Medicins sans Frontieres or MSF in French) from publishing articles in the journal, according to a linkurl:story;http://www.sciencemag.org/cgi/content/short/319/5863/555 in __Science__ magazine today (Feb. 1). Did members of the aid organization break an linkurl:embargo?;http://www.the-scientist.com/blog/display/53943/ Fail to disclose conflicts of interest? Fabricate data? Nope. They just posted

By | February 1, 2008

The editor of __The Lancet__ has banned members of international aid group Doctors Without Borders (Medicins sans Frontieres or MSF in French) from publishing articles in the journal, according to a linkurl:story;http://www.sciencemag.org/cgi/content/short/319/5863/555 in __Science__ magazine today (Feb. 1). Did members of the aid organization break an linkurl:embargo?;http://www.the-scientist.com/blog/display/53943/ Fail to disclose conflicts of interest? Fabricate data? Nope. They just posted a linkurl:critique;http://www.msf.org/msfinternational/invoke.cfm?objectid=82D4C16C-15C5-F00A-25703306040BE471&component=toolkit.article&method=full_html of some __Lancet__ articles on their website. In what's shaping up to be an ugly spat, __Lancet__ editor Richard Horton told __Science__ that the medical journal has "put our relationship with MSF on hold until I have a clear response about how this could have happened." MSF criticized a linkurl:series of articles;http://www.msf.org/source/access/2008/Lancet_Undernutrition_Comment.pdf on curbing malnutrition published in the Jan. 19th issue of __The Lancet__ for, among other shortcomings, not including enough information about ready-made, high-protein therapeutic foods that MSF and other aid organizations distribute to combat acute cases of malnutrition. The MSF critique reads, in part, "Because of weaknesses in analysis and outmoded recommendations, the series is undermining efforts to promote urgently needed change." Horton shot back in the __Science__ story: "MSF has punctured the beginning of an advocacy based on the best science."

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham